India’s response to the US Biosecure Act

US Biosecure Act targets China’s pharma exports while boosting India’s contract manufacturing industry

US Biosecure Act Targets China: India’s Pharma Contract Manufacturing to Witness Remarkable Growth in 3 Years

by Megan Wood
August 13, 2024November 8, 2024

Explore how the US Biosecure Act targets China’s pharmaceutical exports and is expected to double India’s pharma contract manufacturing within three years. Learn about the Act’s implications on global pharma trade and the strategic shift towards India’s manufacturing capabilities.